Effect of Diindolylmethane Supplementation on Low-Grade Cervical Cytological Abnormalities: Double-Blind, Randomised, Controlled Trial
Castanon A, Tristram A, Mesher D, Powell N, Beer H, Ashman S, Fielder H, Fiander A, Sasieni P
Published in British Journal of Cancer
Methodology
Double-blind randomised placebo-controlled trial of 150 mg/day diindolylmethane for 6 months in 551 women with low-grade cervical cytological abnormalities.
Key Findings
No significant difference between DIM and placebo in cytology, colposcopic impression, HPV clearance or CIN2+ rates at 6 months.
Conclusions
Supplemental diindolylmethane did not improve outcomes in low-grade cervical abnormalities.
Limitations
Six-month duration; single dose level; low-grade lesions with high spontaneous regression.
Supplements Studied
No significant difference between DIM and placebo in cytology, colposcopic impression, HPV clearance or CIN2+ rates.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.